Liang Xu
Tianjin University of Traditional Chinese Medicine(CN)St. Michael's Hospital(CA)Nanjing University of Chinese Medicine(CN)Hong Kong Baptist University(HK)University of Kansas(US)University of Toronto(CA)Xiamen University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Morgridge Institute for Research(US)Peking University Cancer Hospital(CN)Zhejiang Cancer Hospital(CN)Tianjin Institute of Pharmaceutical Research (China)(CN)Occupational Cancer Research Centre(CA)Cambridge Electronics (United States)(US)Tianjin People's Hospital(CN)Second Hospital of Tianjin Medical University(CN)Cancer Hospital of Chinese Academy of Medical Sciences(CN)Second Affiliated Hospital of Zhejiang University(CN)Inner Mongolia Medical University(CN)Tianjin Medical University(CN)
Publications by Year
Research Areas
RNA Research and Splicing, RNA modifications and cancer, MicroRNA in disease regulation, Cell death mechanisms and regulation, RNA Interference and Gene Delivery
Most-Cited Works
- → MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells(2009)680 cited
- → Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation(2016)582 cited
- → Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres(2008)392 cited
- Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch.(2012)
- → Discovery of Embelin as a Cell-Permeable, Small-Molecular Weight Inhibitor of XIAP through Structure-Based Computational Screening of a Traditional Herbal Medicine Three-Dimensional Structure Database(2004)340 cited
- → In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis(2017)333 cited
- Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.(2002)